Clinical trial of a prion disease drug candidate begins enrolling participants
News
A new drug candidate designed to slow the progression of prion disease is entering a phase 1 clinical trial, which will evaluate the potential medicine for safety and tolerability. Prion diseases are a class of neurodegenerative disorders that are caused...